Mukhtar, Sameen, and Muhammad Haris. 2023. “Teplizumab: An FDA- Approved Drug, Marks Milestone in Treatment of Type 1 Diabetes”. International Journal of Scientific Reports 10 (1):29-30. https://doi.org/10.18203/issn.2454-2156.IntJSciRep20233870.